Health professionals

Recording from Pancreatic Enzyme Replacement Therapy (PERT) Q&A

Presentations from Non-surgical treatment options: Ablative therapies

Presentations from Non-surgical treatment options: Chemotherapy and clinical trials

Presentations from Pain management within pancreatic cancer, 27 September 2022

Non-surgical treatment options: Chemotherapy and clinical trials

PERT and pancreatic cancer

Presentations from Personalised care in pancreatic cancer workshop, 9 June 2022

Optimal Care Pathway meeting, 30th October 2024

Presentations from Dietetic management and pancreatic cancer, 28 April 2022

Presentations from Supporting patients with pancreatic cancer, March 2022

Presentations from Diabetes and pancreatic cancer, 10 February 2022

Introducing SABR treatment for pancreatic cancer

In Autumn 2020, Pancreatic Cancer UK helped to submit a proposal to NHS England, asking them to commission a type of radiotherapy called SABR (Stereotactic Ablative Body Radiotherapy), for people with locally advanced pancreatic cancer (LAPC). Now, SABR treatment has been commissioned for rollout in England, thanks to a group of healthcare professionals and Pancreatic Cancer UK's Research Involvement Network (RIN).